Netanyahu, Trump appear to abandon Gaza ceasefire negotiations with Hamas
Netanyahu said Israel was now considering "alternative" options to achieve its goals of bringing its hostages home from Gaza and ending the rule of Hamas in the territory. Trump said Hamas did not want to make a deal and he believed the group's leaders would now be "hunted down".
The remarks followed statements made overnight by US envoy Steve Witkoff, who said Hamas was to blame for an impasse at the ceasefire negotiations, mediated by Qatar and Egypt. Netanyahu said Witkoff had got it right, and that Hamas was the obstacle to a deal.
Hamas had given its response to a US-backed ceasefire proposal on Thursday, only for Israel to announced hours later that it was withdrawing its negotiators for consultations.
Hamas has disputed Witkoff's characterisation of the talks and said the negotiators were making progress. It said Witkoff's remarks were aimed at applying pressure on Israel's behalf ahead of a future next round of negotiations.
The proposed ceasefire would have lasted 60 days during which additional aid would be allowed into Gaza, and some of the remaining 50 hostages held by militants there would be freed in return for Palestinian prisoners held by Israel.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
8 minutes ago
- CNA
US axes mRNA vaccine contracts, casting safety doubts
WASHINGTON: President Donald Trump's administration on Tuesday (Aug 5) announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the COVID-19 pandemic and saving millions of lives. The announcement, made by Health Secretary Robert F Kennedy Jr, marks his latest effort to weave vaccine skepticism into the core of US government policy. "We reviewed the science, listened to the experts, and acted," Kennedy said in a statement. The health department's Biomedical Advanced Research and Development Authority (BARDA) is "terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu", he added. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." The changes affect Moderna's mRNA bird flu vaccine - a move the company itself disclosed in May - as well as numerous other programmes, including "rejection or cancellation of multiple pre-award solicitations" from pharmaceutical giants Pfizer and Sanofi. In total, the affected projects are worth "nearly US$500 million," the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move "to preserve prior taxpayer investment." "Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them," Secretary Kennedy said. "That's why we're moving beyond the limitations of mRNA and investing in better solutions." Since taking office, Kennedy, who spent two decades sowing misinformation around immunisation, has overseen a major overhaul of US health policy - firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed - a public-private partnership led by BARDA that poured billions into companies to accelerate development. The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing "to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times."
CNA
8 minutes ago
- CNA
Oil prices rebound from 5-week low on Trump threats on Russian crude buyers
TOKYO :Oil prices climbed on Wednesday, rebounding from a five-week low in the previous day, on concerns of supply disruptions after U.S. President Donald Trump's threats of tariffs on India over its Russian crude purchases. Brent crude futures rose 29 cents, or 0.4 per cent, to $67.93 a barrel by 0119 GMT while U.S. West Texas Intermediate crude was at $65.44 a barrel, up 28 cents, or 0.4 per cent. Both contracts fell by more than $1 on Tuesday to settle at their lowest in five weeks, marking a fourth session of losses, on oversupply concerns from OPEC+'s planned September output hike. "Investors are assessing whether India will reduce its Russian crude purchases in response to Trump's threats, which could tighten supply, but it remains to be seen if that will actually happen," said Yuki Takashima, economist at Nomura Securities. "If India's imports remain steady, WTI is likely to stay within the $60-$70 range for the rest of the month," he said. The Organization of the Petroleum Exporting Countries and its allies, together known as OPEC+, agreed on Sunday to raise oil production by 547,000 barrels per day for September, a move that will end its most recent output cut earlier than planned. The OPEC+ pumps about half of the world's oil and had been curtailing production for several years to support the market, but the group introduced a series of accelerated output hikes this year to regain market share. At the same time, U.S. demands for India to stop buying Russian oil as Washington seeks ways to push Moscow for a peace deal with Ukraine could upset supply flows as Indian refiners seek alternatives and Russian crude is redirected to other buyers. Trump on Tuesday again threatened higher tariffs on Indian goods over the country's Russian oil purchases over the next 24 hours. Trump also said declining energy prices could pressure Russian President Vladimir Putin to halt the war in Ukraine. New Delhi called Trump's threat "unjustified" and vowed to protect its economic interests, deepening a trade rift between the two countries. Nomura's Takashima also pointed to industry data showing crude inventories in the U.S., the world's biggest oil consumer, as supportive for the oil market. U.S. crude inventories fell by 4.2 million barrels last week, sources citing American Petroleum Institute figures said on Tuesday. That compares with a Reuters poll estimate of a 600,000 barrels draw for the week to August 1. [API/S]
CNA
8 minutes ago
- CNA
CNA938 Rewind - Israel-Hamas war: Is Netanyahu's plan to take full control of Gaza a gamble?
Israeli Prime Minister Benjamin Netanyahu is reportedly leaning towards expanding the war on Gaza for a full takeover. But Israeli media reports say, there are objections from within the Israel Defense Forces. Meanwhile, a group of some 600 retired Israeli officials have written to US President Donald Trump to press Israel to end the war in Gaza. Hairianto Diman and Susan Ng get the latest from Prof Zach Levey, Visiting Professor, International Affairs Program, University of Colorado at Boulder.
